Showing results (1-10 of 195) with videos related to
Sort By:
Pageof 20
Journal of Thoracic Disease|June 29, 2018
Thymic tumors and immune checkpoint inhibitorsShintaro Yokoyama, Hiroaki MiyoshiJournal of Thoracic Disease|January 15, 2021
Comparison of PD-L1 immunohistochemical assays and the significance of PD-L1 expression in thymomaShintaro Yokoyama, Hiroaki MiyoshiPathology International|June 16, 2017
Papillary thyroid carcinoma expressing CD20Yuya Sasaki, Masao Seto, Hiroaki Miyoshi, et al.The Annals of Thoracic Surgery|January 23, 2016
Clinicopathologic and Prognostic Implications of Programmed Death Ligand 1 Expression in ThymomaShintaro Yokoyama, Hiroaki Miyoshi, Tatsuya Nishi, et al.Plos One|November 15, 2017
Clinicopathological and prognostic value of transforming acidic coiled-coil-containing protein 3 (TACC3) expression in soft tissue sarcomasKotaro Matsuda, Hiroaki Miyoshi, Koji Hiraoka, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2016
Prognostic Value of Programmed Death Ligand 1 and Programmed Death 1 Expression in Thymic CarcinomaShintaro Yokoyama, Hiroaki Miyoshi, Kazutaka Nakashima, et al.Human Pathology|March 22, 2017
Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinomaToshihiro Hashiguchi, Hiroaki Miyoshi, Kazutaka Nakashima, et al.Hematological Oncology|March 31, 2018
Expression of programmed death ligand 1 is associated with poor prognosis in myeloid sarcoma patientsKeisuke Kawamoto, Hiroaki Miyoshi, Takaharu Suzuki, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 1, 2025
[Key points in the diagnosis of T-cell lymphoma in the 5th edition of the WHO Classification (2022)]Hiroaki MiyoshiTraffic Injury Prevention|October 2, 2024
Change in the collision avoidance performance of autonomous emergency braking systemsHiroaki MiyoshiPageof 20